Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 15;199(8):952-960.
doi: 10.1164/rccm.201809-1677CI.

Balanced Crystalloid Solutions

Affiliations
Review

Balanced Crystalloid Solutions

Matthew W Semler et al. Am J Respir Crit Care Med. .

Abstract

Intravenous fluid therapy is the most common intervention received by acutely ill patients. Historically, saline (0.9% sodium chloride) has been the most frequently administered intravenous fluid, especially in North America. Balanced crystalloid solutions (e.g., lactated Ringer's, Plasma-Lyte) are an increasingly used alternative to saline. Balanced crystalloids have a sodium, potassium, and chloride content closer to that of extracellular fluid and, when given intravenously, have fewer adverse effects on acid-base balance. Preclinical research has demonstrated that saline may cause hyperchloremic metabolic acidosis, inflammation, hypotension, acute kidney injury, and death. Studies of patients and healthy human volunteers suggest that even relatively small volumes of saline may exert physiological effects. Randomized trials in the operating room have demonstrated that using balanced crystalloids rather than saline prevents the development of hyperchloremic metabolic acidosis and may reduce the need for vasopressors. Observational studies among critically ill adults have associated receipt of balanced crystalloids with lower rates of complications, including acute kidney injury and death. Most recently, large randomized trials among critically ill adults have examined whether balanced crystalloids result in less death or severe renal dysfunction than saline. Although some of these trials are still ongoing, a growing body of evidence raises fundamental concerns regarding saline as the primary intravenous crystalloid for critically ill adults and highlights fundamental unanswered questions for future research about fluid therapy in critical illness.

Keywords: acute kidney injury; balanced crystalloids; critical illness; intravenous fluid; saline.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Effects of crystalloid composition on plasma electrolytes and organ function. The figure displays the electrolyte content of human plasma and of each intravenous crystalloid solution. Gray boxes indicate the expected effect of administration of each crystalloid on plasma electrolytes. Panels on the right summarize detrimental effects of saline-induced hyperchloremic metabolic acidosis on the cardiovascular and renal systems reported in preclinical and clinical research.
Figure 2.
Figure 2.
Effect of balanced crystalloids versus saline on mortality among critically ill adults. The odds ratios (ORs) and 95% confidence intervals (CIs) for in-hospital mortality with balanced crystalloids compared with saline are displayed for the four large randomized trials among critically ill adults (–59).

Comment in

Similar articles

Cited by

References

    1. Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr. 2008;27:179–188. - PubMed
    1. Glassford NJ, Bellomo R. The complexities of intravenous fluid research: questions of scale, volume, and accumulation. Korean J Crit Care Med. 2016;31:276–299.
    1. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369:1243–1251. - PubMed
    1. Hammond NE, Taylor C, Saxena M, Liu B, Finfer S, Glass P, et al. Resuscitation fluid use in Australian and New Zealand intensive care units between 2007 and 2013. Intensive Care Med. 2015;41:1611–1619. - PubMed
    1. Morgan TJ. The ideal crystalloid – what is ‘balanced’? Curr Opin Crit Care. 2013;19:299–307. - PubMed

Publication types

MeSH terms

Substances